[Federal Register Volume 67, Number 53 (Tuesday, March 19, 2002)]
[Notices]
[Pages 12571-12572]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-6620]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Food Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces a forthcoming meeting of a public 
advisory committee of the Food and Drug Administration (FDA). The 
meeting will be open to the public.
    Name of Committee: Food Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on scientific issues related to FDA's 
regulatory responsibilities.
    Date and Time: The meeting will be held on April 4, 2002, from 9 
a.m. to 6 p.m. and April 5, 2002, from 8:30 a.m. to 2 p.m.
    Location: Marriott Hotel, Grand Ballroom, 6400 Ivy Lane, Greenbelt, 
MD, 301-441-3700.
    Contact Person: Catherine M. DeRoever, Center for Food Safety and 
Applied Nutrition (HFS-6), Food and Drug Administration, 5100 Paint 
Branch Pkwy., College Park, MD 20740, 301-436-2397, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 10564. Please call the Information Line for 
up-to-date information on this meeting.

[[Page 12572]]

    Agenda: The purpose of this meeting is to discuss general 
scientific principles related to quality factors for infant formula. 
The committee will also be asked to discuss the scientific issues 
related to the generalization of findings from a clinical study using 
preterm infant formula consumed by preterm infants to a term infant 
formula intended for use by term infants.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by April 1, 2002. 
Oral presentations from the public will be scheduled on April 4, 2002, 
between approximately 1 p.m. and 6 p.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before April 1, 2002, 
and submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Catherine M. 
DeRoever at least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: March 14, 2002.
Linda A. Suydam,
Senior Associate Commissioner for Communications and Constituent 
Relations.
[FR Doc. 02-6620 Filed 3-14-02; 4:50 pm]
BILLING CODE 4160-01-S